These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 28343895)

  • 1. Pharmacokinetic profile of promising acetylcholinesterase reactivators K027 and K203 in experimental pigs.
    Karasova JZ; Kvetina J; Tacheci I; Radochova V; Musilek K; Kuca K; Bures J
    Toxicol Lett; 2017 May; 273():20-25. PubMed ID: 28343895
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetic study of two acetylcholinesterase reactivators, trimedoxime and newly synthesized oxime K027, in rat plasma.
    Karasova JZ; Chladek J; Hroch M; Josef F; Hnidkova D; Kuca K
    J Appl Toxicol; 2013 Jan; 33(1):18-23. PubMed ID: 21717485
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Encapsulation of oxime K027 into cucurbit[7]uril: In vivo evaluation of safety, absorption, brain distribution and reactivation effectiveness.
    Zdarova Karasova J; Hepnarova V; Andrys R; Lisa M; Jost P; Muckova L; Pejchal J; Herman D; Jun D; Kassa J; Kuca K
    Toxicol Lett; 2020 Mar; 320():64-72. PubMed ID: 31794810
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An evaluation of therapeutic and reactivating effects of newly developed oximes (K156, K203) and commonly used oximes (obidoxime, trimedoxime, HI-6) in tabun-poisoned rats and mice.
    Kassa J; Karasova J; Musilek K; Kuca K
    Toxicology; 2008 Jan; 243(3):311-6. PubMed ID: 18054821
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HI-6 oxime (an acetylcholinesterase reactivator): blood plasma pharmacokinetics and organ distribution in experimental pigs.
    Kuneš M; Květina J; Bureš J; Karasová JZ; Pavlík M; Tachecí I; Musílek K; Kuca K
    Neuro Endocrinol Lett; 2014; 35 Suppl 2():191-6. PubMed ID: 25638385
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapeutic and reactivating efficacy of oximes K027 and K203 against a direct acetylcholinesterase inhibitor.
    Antonijevic E; Musilek K; Kuca K; Djukic-Cosic D; Vucinic S; Antonijevic B
    Neurotoxicology; 2016 Jul; 55():33-39. PubMed ID: 27177985
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intravenous application of HI-6 salts (dichloride and dimethansulphonate) in pigs: comparison with pharmacokinetics profile after intramuscular administration.
    Zdarova Karasova J; Zemek F; Kunes M; Kvetina J; Chladek J; Jun D; Bures J; Tachecí I; Kuca K
    Neuro Endocrinol Lett; 2013; 34 Suppl 2():74-8. PubMed ID: 24362096
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The biodistribution and pharmacokinetics of the oxime acetylcholinesterase reactivator RS194B in guinea pigs.
    Malfatti MA; Enright HA; Be NA; Kuhn EA; Hok S; McNerney MW; Lao V; Nguyen TH; Lightstone FC; Carpenter TS; Bennion BJ; Valdez CA
    Chem Biol Interact; 2017 Nov; 277():159-167. PubMed ID: 28941624
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Partition of bispyridinium oximes (trimedoxime and K074) administered in therapeutic doses into different parts of the rat brain.
    Karasova JZ; Zemek F; Bajgar J; Vasatova M; Prochazka P; Novotny L; Kuca K
    J Pharm Biomed Anal; 2011 Apr; 54(5):1082-7. PubMed ID: 21146949
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dose-response modeling of reactivating potency of oximes K027 and K203 against a direct acetylcholinesterase inhibitor in rat erythrocytes.
    Antonijevic E; Musilek K; Kuca K; Djukic-Cosic D; Curcic M; Miladinovic DC; Bulat Z; Antonijevic B
    Food Chem Toxicol; 2018 Nov; 121():224-230. PubMed ID: 30176309
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of Oxime Encapsulation on Acetylcholinesterase Reactivation: Pharmacokinetic Study of the Asoxime-Cucurbit[7]uril Complex in Mice Using Hydrophilic Interaction Liquid Chromatography-Mass Spectrometry.
    Andrýs R; Klusoňová A; Lísa M; Kassa J; Karasová JŽ
    Mol Pharm; 2021 Jun; 18(6):2416-2427. PubMed ID: 34019427
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of possible inhibition of human liver drug metabolizing cytochromes P450 by two new acetylcholinesterase oxime-type reactivators.
    Spicakova A; Anzenbacher P; Liskova B; Kuca K; Fusek J; Anzenbacherova E
    Food Chem Toxicol; 2016 Feb; 88():100-4. PubMed ID: 26747974
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics of atropine in dogs after i.m. injection with newly developed dry/wet combination autoinjectors containing HI 6 or HLö 7.
    Thiermann H; Radtke M; Spöhrer U; Klimmek R; Eyer P
    Arch Toxicol; 1996; 70(5):293-9. PubMed ID: 8852700
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacological and toxicological in vitro and in vivo effect of higher doses of oxime reactivators.
    Hepnarova V; Muckova L; Ring A; Pejchal J; Herman D; Misik J; Hrabinova M; Jun D; Soukup O
    Toxicol Appl Pharmacol; 2019 Nov; 383():114776. PubMed ID: 31629733
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Revealing the importance of linkers in K-series oxime reactivators for tabun-inhibited AChE using quantum chemical, docking and SMD studies.
    Ghosh S; Chandar NB; Jana K; Ganguly B
    J Comput Aided Mol Des; 2017 Aug; 31(8):729-742. PubMed ID: 28646405
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics of the oximes HI 6 and HLö 7 in dogs after i.m. injection with newly developed dry/wet autoinjectors.
    Spöhrer U; Thiermann H; Klimmek R; Eyer P
    Arch Toxicol; 1994; 68(8):480-9. PubMed ID: 7802588
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The acetylcholinesterase oxime reactivator HI-6 in man: pharmacokinetics and tolerability in combination with atropine.
    Clement JG; Bailey DG; Madill HD; Tran LT; Spence JD
    Biopharm Drug Dispos; 1995 Jul; 16(5):415-25. PubMed ID: 8527690
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The efficacy of HI-6 DMS in a sustained infusion against percutaneous VX poisoning in the guinea-pig.
    Whitmore C; Cook AR; Mann T; Price ME; Emery E; Roughley N; Flint D; Stubbs S; Armstrong SJ; Rice H; Tattersall JEH
    Toxicol Lett; 2018 Sep; 293():207-215. PubMed ID: 29129798
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acetylcholinesterase reactivators (HI-6, obidoxime, trimedoxime, K027, K075, K127, K203, K282): structural evaluation of human serum albumin binding and absorption kinetics.
    Zemek F; Zdarova JK; Sepsova V; Kuca K
    Int J Mol Sci; 2013 Aug; 14(8):16076-86. PubMed ID: 23917882
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Asoxime (HI-6) impact on dogs after one and tenfold therapeutic doses: assessment of adverse effects, distribution, and oxidative stress.
    Pohanka M; Novotny L; Zdarova-Karasova J; Bandouchova H; Zemek F; Hrabinova M; Misik J; Kuca K; Bajgar J; Zitka O; Cernei N; Kizek R; Pikula J
    Environ Toxicol Pharmacol; 2011 Jul; 32(1):75-81. PubMed ID: 21787733
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.